1
|
Dandurand C, Zhou L, Fitzmaurice G, Prakash S, Redekop G, Haw C, Gooderham P. Quality of life scores in patients with unruptured cerebral aneurysm: Prospective cohort study. J Clin Neurosci 2021; 91:350-353. [PMID: 34373051 DOI: 10.1016/j.jocn.2021.07.024] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/14/2020] [Revised: 07/15/2021] [Accepted: 07/16/2021] [Indexed: 10/20/2022]
Abstract
BACKGROUND Living with the diagnosis of an unruptured cerebral aneurysm can understandably cause distress to a patient. The goal of preventive treatment is to increase the number of years with good quality of life (QoL). OBJECTIVE This study aimed to measure the effect of unruptured intracranial aneurysm treatment on change in QoL scores measured by the SF36 and EQ-5D-5L. METHODS We prospectively collected SF36 and EQ-5D-5L survey data for patients with unruptured intracranial aneurysms at two time-points over 1 year between 2 treatment groups: observation and intervention (microsurgical and endovascular). Multivariable linear regression was used to examine treatment group differences in the mean change in scores from baseline to 1 year when adjusted for covariates. RESULTS 92 patients were included in the observation group and 68 patients were included in the intervention group, for a total of 160 patients. The intervention group had lower SF36 total scores at baseline (p = 0.001). With multivariate linear regression models, the effect of treatment on mean change in SF36 total score from baseline to 1 year was not statistically significant (p = 0.4); similarly, there was no difference in mean change in EQ-5D-5L. CONCLUSION In this large prospective study, preventive aneurysm treatment was not associated with a significant change in QoL score at 1 year compared to observation as measured by the SF36 and EQ-5D-5L. Further studies are needed to explore the lower QoL scores in patients seeking treatment and its impact on management decision making.
Collapse
Affiliation(s)
- Charlotte Dandurand
- UBC, Faculty of Medicine, Division of Neurosurgery, Vancouver, Canada; T.H. Chan School of Public Health, Harvard University, Boston, MA, United States
| | - Lily Zhou
- T.H. Chan School of Public Health, Harvard University, Boston, MA, United States; UBC, Faculty of Medicine, Division of Neurology, Vancouver, Canada
| | - Garrett Fitzmaurice
- T.H. Chan School of Public Health, Harvard University, Boston, MA, United States
| | - Swetha Prakash
- UBC, Faculty of Medicine, Division of Neurosurgery, Vancouver, Canada.
| | - Gary Redekop
- UBC, Faculty of Medicine, Division of Neurosurgery, Vancouver, Canada
| | - Charles Haw
- UBC, Faculty of Medicine, Division of Neurosurgery, Vancouver, Canada
| | - Peter Gooderham
- UBC, Faculty of Medicine, Division of Neurosurgery, Vancouver, Canada
| |
Collapse
|
2
|
Saigle V, Asad S, Presseau J, Chassé M, McIntyre L, English SW. Do patient-reported outcome measures for SAH include patient, family, and caregiver priorities? A scoping review. Neurology 2019; 92:281-295. [PMID: 30626652 DOI: 10.1212/wnl.0000000000006883] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/21/2018] [Accepted: 10/03/2018] [Indexed: 11/15/2022] Open
Abstract
OBJECTIVE To systematically describe literature that identified patient/family/caregiver priorities for subarachnoid hemorrhage (SAH)-specific patient-reported outcome measures (PROMs), developed novel SAH PROMs by incorporating patient/family/caregiver perspectives, or involved patient/family/caregiver perspectives in evaluating existing SAH PROMs. METHODS We conducted a scoping review using Embase and Ovid MEDLINE from inception to February 6, 2018. Study eligibility and data extraction was performed independently and in duplicate. For each eligible citation, we abstracted information about study population, design, type of patient involvement, and outcome measures. We planned a descriptive summary of all included studies. RESULTS Our search yielded 4,961 citations, of which 15 met our eligibility criteria. Four of these included duplicate data, so our final sample consisted of 12 articles. There were 879 patients with SAH and 241 carers from the 11/12 articles that reported these data. One additional study involved 70 individuals but did not specify the number of carers or patients. We did not find any studies where SAH survivors or their families were directly involved in the full continuum of PROM outcome conceptualization from development to evaluation. We found 41 measures identified by patients with SAH. We identified only 2 PROMs developed with patients and only one that was a post hoc evaluation by patients. These 3 PROMs are subarachnoid hemorrhage outcome tool, Wessex Patient Carer Questionnaire, and Functional Status Examination, respectively. CONCLUSION We identified 3 PROMs that have involved patients in some way, but the extent to which they reflect patient priorities remains unclear. More work is needed to ensure SAH research is not overlooking outcomes that are important to patients.
Collapse
Affiliation(s)
- Victoria Saigle
- From the Clinical Epidemiology Program (Centre for Transfusion Research) (V.S., S.A., L.M., S.W.E.), Ottawa Hospital Research Institute (J.P.); School of Epidemiology and Public Health (J.P., S.W.E.) and Department of Medicine (Critical Care) (S.W.E., L.M.), University of Ottawa; and Department of Medicine (Critical Care) (M.C.), University of Montreal Hospital, Canada
| | - Sarah Asad
- From the Clinical Epidemiology Program (Centre for Transfusion Research) (V.S., S.A., L.M., S.W.E.), Ottawa Hospital Research Institute (J.P.); School of Epidemiology and Public Health (J.P., S.W.E.) and Department of Medicine (Critical Care) (S.W.E., L.M.), University of Ottawa; and Department of Medicine (Critical Care) (M.C.), University of Montreal Hospital, Canada
| | - Justin Presseau
- From the Clinical Epidemiology Program (Centre for Transfusion Research) (V.S., S.A., L.M., S.W.E.), Ottawa Hospital Research Institute (J.P.); School of Epidemiology and Public Health (J.P., S.W.E.) and Department of Medicine (Critical Care) (S.W.E., L.M.), University of Ottawa; and Department of Medicine (Critical Care) (M.C.), University of Montreal Hospital, Canada
| | - Michaël Chassé
- From the Clinical Epidemiology Program (Centre for Transfusion Research) (V.S., S.A., L.M., S.W.E.), Ottawa Hospital Research Institute (J.P.); School of Epidemiology and Public Health (J.P., S.W.E.) and Department of Medicine (Critical Care) (S.W.E., L.M.), University of Ottawa; and Department of Medicine (Critical Care) (M.C.), University of Montreal Hospital, Canada
| | - Lauralyn McIntyre
- From the Clinical Epidemiology Program (Centre for Transfusion Research) (V.S., S.A., L.M., S.W.E.), Ottawa Hospital Research Institute (J.P.); School of Epidemiology and Public Health (J.P., S.W.E.) and Department of Medicine (Critical Care) (S.W.E., L.M.), University of Ottawa; and Department of Medicine (Critical Care) (M.C.), University of Montreal Hospital, Canada
| | - Shane W English
- From the Clinical Epidemiology Program (Centre for Transfusion Research) (V.S., S.A., L.M., S.W.E.), Ottawa Hospital Research Institute (J.P.); School of Epidemiology and Public Health (J.P., S.W.E.) and Department of Medicine (Critical Care) (S.W.E., L.M.), University of Ottawa; and Department of Medicine (Critical Care) (M.C.), University of Montreal Hospital, Canada.
| |
Collapse
|